Security key
05338F306
Avalo Therapeutics, Inc. - Common Stock, $0.001 par value (AVTX)
CUSIP: 05338F306
Q2 2024 13F Holders as of 30 Jun 2024
- Security type / class
- Equity / Common Stock, $0.001 par value
- Total 13F shares
- 771,102
- Total 13F value
- $9,615,066
- Share change
- +683,595
- SEC-reported price per share
- $12.47
- Number of holders
- 21
- Value change
- +$8,430,049
- Number of buys
- 11
- Number of sells
- 8
- Shares outstanding
- 57,788,980
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2024
Institutions
21
Top holders
10
AVTX full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2024
Previous quarter: Q1 2024
Avalo Therapeutics, Inc. SEC filings
Avalo Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 05338F306
Recent filing periods:
Ownership snapshot
Top reported holders of AVTX - Avalo Therapeutics, Inc. - Common Stock, $0.001 par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Ikarian Capital, LLC
Disclosed value leader
Ikarian Capital, LLC
Comparable rows
15/15
Latest evidence
31 Mar 2024
13F
Lead comparable stake: 0.08%
Showing 1-6 of 15 holder rows.
Quick read
Ikarian Capital, LLC leads the comparable SEC ownership view at 0.08%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Ikarian Capital, LLC's linked filing trail.
Comparable ownership
Top 5
Ikarian Capital, LLC
0.08%
Sio Capital Management, LLC
0.02%
Affinity Asset Advisors, LLC
0.02%
UBS Group AG
0.01%
ADAR1 Capital Management, LLC
0.01%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Ikarian Capital, LLC |
13F
Company
|
0.08%
|
$1,014,594
46,648 shares
|
— | 31 Mar 2024 |
| Sio Capital Management, LLC |
13F
Company
|
0.02%
|
$220,784
10,151 shares
|
— | 31 Mar 2024 |
| Affinity Asset Advisors, LLC |
13F
Company
|
0.02%
|
$217,500
10,000 shares
|
— | 31 Mar 2024 |
| UBS Group AG |
13F
Company
|
0.01%
|
$167,758
7,713 shares
|
— | 31 Mar 2024 |
| ADAR1 Capital Management, LLC |
13F
Company
|
0.01%
|
$130,500
6,000 shares
|
— | 31 Mar 2024 |
| NATIXIS |
13F
Company
|
0%
|
$54,636
2,512 shares
|
— | 31 Mar 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
21
Shares
771,102
Rows available
21
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2024 vs Q1 2024 Across Filers
Q1 2024 holders
18
Q2 2024 holders
21
Holder diff
3
| Investor | Q1 2024 Shares | Q2 2024 Shares | Share Diff | Share Chg % | Q1 2024 value | Q2 2024 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend